Home LiteratureArticle Details
PMID: 37534630 Published · ppublish English

PMS2 or PMS2CL? Characterization of variants detected in the 3' of the PMS2 gene.

Genes, chromosomes & cancer ·Vol. 63 ·No. 1 ·2024-00-00

Bouras A, Lefol C, Ruano E, Grand-Masson C, Wang Q

Abstract

PMS2 germline pathogenic variants are one of the major causes for Lynch syndrome and constitutional mismatch repair deficiencies. Variant identification in the 3' region of this gene is complicated by the presence of the pseudogene PMS2CL which shares a high sequence homology with PMS2. Consequently, short-fragment screening strategies (NGS, Sanger) may fail to discriminate variant's gene localization. Using a comprehensive analysis strategy, we assessed 42 NGS-detected variants in 76 patients and found 32 localized on PMS2 while 6 on PMS2CL. Interestingly, four variants were detected in either of them in different patients. Clinical phenotype was well correlated to genotype, making it very helpful in variant assessment. Our findings emphasize the necessity of more specific complementary analyses to confirm the gene origin of each variant detected in different individuals in order to avoid variant misinterpretation. In addition, we characterized two PMS2 genomic alterations involving Alu-mediated tandem duplication and gene conversion. Those mechanisms seemed to be particularly favored in PMS2 which contribute to frequent genomic rearrangements in the 3' region of the gene.

Keywords
Lynch syndrome PMS2 PMS2CL next-generation sequencing pseudogene
Article Info
Journal
Genes, chromosomes & cancer
Abbr.
Genes Chromosomes Cancer
ISSN
1098-2264
Published
2024-00-00
Language
English
Country/Region
United States
NLM ID
9007329
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com